Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
Top Cited Papers
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 18 (10), 2324-2331.e4
- https://doi.org/10.1016/j.cgh.2019.12.026
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Role of Hepatic Progenitor Cells in Nonalcoholic Fatty Liver Disease Development: Cellular Cross-Talks and Molecular NetworksInternational Journal of Molecular Sciences, 2013
- Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-AnalysisInternational Journal of Endocrinology, 2013
- Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?European Heart Journal, 2012
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseGut, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDJournal of Hepatology, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.Stroke, 1990